当前位置: X-MOL 学术J. Pharm. Anal. › 论文详情
The current status of anti GPCR drugs against different cancers
Journal of Pharmaceutical Analysis ( IF 4.44 ) Pub Date : 2020-01-11 , DOI: 10.1016/j.jpha.2020.01.001
Sana Usman; Maria Khawer; Shazia Rafique; Zara Naz; Komal Saleem

G protein coupled receptors (GPCRs) have been emerged as most potential target for a number of drug discovery programs ranging from control of blood pressure, diabetes, cure for genetic diseases to treatment of cancer. A panel of different ligands including hormones, peptides, ions and small molecules is responsible for activation of these receptors. Molecular genetics have identified key GPCRs, whose mutations or altered expression are linked with tumorgenicity. In this review, we discussed recent advances regarding the involvement of GPCRs in the development of cancers and approaches to manipulate the mechanism behind GPCRs involved tumor growth and metastasis to treat different types of human cancer. This review provides an insight of the current scenario of GPCR-targeted therapy, progress to date and the challenges in the development of anticancer drugs.
更新日期:2020-01-13

 

全部期刊列表>>
化学/材料学中国作者研究精选
Springer Nature 2019高下载量文章和章节
《科学报告》最新环境科学研究
ACS材料视界
自然科研论文编辑服务
中南大学国家杰青杨华明
剑桥大学-
中国科学院大学化学科学学院
材料化学和生物传感方向博士后招聘
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug